Radius Health Stock

Radius Health EBIT

Delisted·Jul 10, 2025

The EBIT of Radius Health (RDUS) as of Aug 12, 2026 is -294.54 M USD. In the previous year, EBIT was -3.93 M USD — a change of 7,404.08% (lower).

EBIT

-294.54 MUSD

YoY

7,404.08%

Last updated:

In 2026, Radius Health's EBIT was -294.54 M USD, a 7,404.08% increase from the -3.93 M USD EBIT recorded in the previous year.

The Radius Health EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2023
-3.93 base
Jan 1, 2024
-294.54 base
Jan 1, 2025 (e)
-26.18 base
Jan 1, 2025 (e)
-59.28 base
Jan 1, 2026 (e)
-28.42 base
Jan 1, 2027 (e)
-30.25 base
Jan 1, 2028 (e)
-26.74 base
Jan 1, 2029 (e)
-27.16 base
YEAREBIT (M USD)
2029 est -27.16
2028 est -26.74
2027 est -30.25
2026 est -28.42
2025 est -59.28
2025 est -26.18
2024 -294.54
2023 -3.93
2022 225.91
2021 213.73
2020 6.85
2019 -108.63
2018 -198.89
2017 -246.16
2016 -184.95
2015 -99.08
2014 20.32
2013 -67.37
2012 53.67
2011 -0.05
2010 -0.03
2009 -57.61
2008 402.28
2007 213.56
2006 175.06
2005 231.07
Access this data via the Eulerpool API

Radius Health Revenue

Radius Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
2.88 B USD
-3.93 M USD
-25.79 M USD
Jan 1, 2024
2.74 B USD
-294.54 M USD
-266.41 M USD
Jan 1, 2025 (e)
2.78 B USD
-26.18 M USD
-79.43 M USD
Jan 1, 2025 (e)
2.85 B USD
-59.28 M USD
0.00 USD
Jan 1, 2026 (e)
2.96 B USD
-28.42 M USD
7.67 M USD
Jan 1, 2027 (e)
3.23 B USD
-30.25 M USD
35.52 M USD
Jan 1, 2028 (e)
2.85 B USD
-26.74 M USD
67.97 M USD
Jan 1, 2029 (e)
2.90 B USD
-27.16 M USD
78.98 M USD

Radius Health Margins

Radius Health stock margins

The Radius Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Radius Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Radius Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
10.68 %
-0.14 %
-0.89 %
Jan 1, 2024
6.47 %
-10.75 %
-9.73 %
Jan 1, 2025 (e)
6.47 %
-0.94 %
-2.85 %
Jan 1, 2025 (e)
6.47 %
-2.08 %
0.00 %
Jan 1, 2026 (e)
6.47 %
-0.96 %
0.26 %
Jan 1, 2027 (e)
6.47 %
-0.94 %
1.10 %
Jan 1, 2028 (e)
6.47 %
-0.94 %
2.38 %
Jan 1, 2029 (e)
6.47 %
-0.94 %
2.72 %

Radius Health Stock analysis

What does Radius Health do? Radius Health Inc. is an American pharmaceutical company specializing in the research, development, and marketing of products in the areas of osteoporosis, cancer therapy, and endocrinology. The company was founded in 2003 and is headquartered in Waltham, Massachusetts. The history of Radius Health Inc. began with the discovery of a new compound called Abaloparatide, which was intended for use in the treatment of osteoporosis. The company initiated a Phase III clinical trial to evaluate the efficacy and tolerability of the medication. In 2016, Abaloparatide was approved by the U.S. Food and Drug Administration (FDA) for the treatment of postmenopausal osteoporosis. Since then, Radius Health Inc. has evolved into a leading company specializing in improving women's health. The company has expanded its activities to include oncology and endocrinology and relies on innovative technologies and research to provide better treatment options and medications for patients. The business model of Radius Health Inc. is based on the development and marketing of cost-effective and effective products for the treatment of diseases. The company conducts extensive clinical research and strives to develop new drugs and therapies to improve the lives of women. Radius Health Inc. employs an open and agile corporate culture that promotes innovation and prioritizes the needs of patients. The products offered by Radius Health Inc. include a wide range of medications used in the treatment of osteoporosis, breast cancer, and other diseases. Abaloparatide, the company's flagship product, is a recombinant peptide agonist that stimulates bone formation and reduces the risk of fractures in postmenopausal women. Other products include Elacestrant, an investigative drug for the treatment of breast cancer, and RAD1901, a selective estrogen receptor modulator used in the treatment of hormone-dependent cancers. The company is also active in the field of digital health. Radius Health Inc. has developed an augmented reality app that assists doctors and patients in visualizing bone fractures and other conditions. The app is currently being tested in clinical trials and is expected to be widely used in the future. Overall, Radius Health Inc. is known for its innovative research activities and efforts to improve women's health. The company has an experienced and dedicated team of researchers, scientists, and executives working together to create better treatment options for patients. With a strong pipeline of products and a vision for the future of healthcare, Radius Health Inc. is on track to become a leading provider of medical products and services. Radius Health is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Radius Health's EBIT

Radius Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Radius Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Radius Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Radius Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Radius Health stock

EBIT of Radius Health is -294.54 M USD in 2026.

EBIT of Radius Health changed from -3.93 M USD to -294.54 M USD, representing a 7,404.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Radius Health since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Radius Health historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Radius Health

All Key Metrics — Radius Health